Cargando…
A ferroptosis-inducing biomimetic nanocomposite for the treatment of drug-resistant prostate cancer
Second-generation androgen receptor (AR) inhibitors such as enzalutamide are the first-line treatments for castration-resistant prostate cancer (CRPC). Resistance to enzalutamide will greatly increase the difficulty of prostate cancer treatment and reduce the survival time of patients. However, drug...
Autores principales: | Chen, Jiyuan, Wang, Yujie, Han, Lu, Wang, Rong, Gong, Chunai, Yang, Gang, Li, Zhe, Gao, Shen, Yuan, Yongfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649379/ https://www.ncbi.nlm.nih.gov/pubmed/36388460 http://dx.doi.org/10.1016/j.mtbio.2022.100484 |
Ejemplares similares
-
Intravenous delivery of enzalutamide based on high drug loading multifunctional graphene oxide nanoparticles for castration-resistant prostate cancer therapy
por: Jiang, Wenjun, et al.
Publicado: (2020) -
Biomimetic semiconducting polymer dots for highly specific NIR-II fluorescence imaging of glioma
por: Men, Xiaoju, et al.
Publicado: (2022) -
Biomimetic hydrogel derived from decellularized dermal matrix facilitates skin wounds healing
por: Yu, Yaling, et al.
Publicado: (2023) -
Drug-independent NADPH-consuming micelles collaborate with ROS-generator for cascade ferroptosis amplification by impairing redox homeostasis
por: Yu, Fangying, et al.
Publicado: (2023) -
Introducing a New Experimental Islet Transplantation Model using Biomimetic Hydrogel and a Simple High Yield Islet Isolation Technique
por: Ayenehdeh, Jamal Mohammadi, et al.
Publicado: (2017)